Literature DB >> 25414437

Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?

Anna L Godfrey1, Jyoti Nangalia2, E Joanna Baxter3, Charles E Massie4, David G Kent4, Elli Papaemmanuil5, Peter J Campbell5, Anthony R Green1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25414437      PMCID： PMC4239339          DOI： 10.1182/blood-2014-09-603043

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity.

Authors:  Chloe James; Frederic Mazurier; Sabrina Dupont; Ronan Chaligne; Isabelle Lamrissi-Garcia; Micheline Tulliez; Eric Lippert; François-Xavier Mahon; Jean-Max Pasquet; Gabriel Etienne; François Delhommeau; Stephane Giraudier; William Vainchenker; Hubert de Verneuil
Journal:  Blood       Date:  2008-07-08       Impact factor: 22.113

2.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

3.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

4.  Evidence that hematopoiesis may be a stochastic process in vivo.

Authors:  J L Abkowitz; S N Catlin; P Guttorp
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

5.  Clonal analyses reveal associations of JAK2V617F homozygosity with hematologic features, age and gender in polycythemia vera and essential thrombocythemia.

Authors:  Anna L Godfrey; Edwin Chen; Francesca Pagano; Yvonne Silber; Peter J Campbell; Anthony R Green
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

6.  JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.

Authors:  Juan Li; Dominik Spensberger; Jong Sook Ahn; Shubha Anand; Philip A Beer; Cedric Ghevaert; Edwin Chen; Ariel Forrai; Linda M Scott; Rita Ferreira; Peter J Campbell; Steve P Watson; Pentao Liu; Wendy N Erber; Brian J P Huntly; Katrin Ottersbach; Anthony R Green
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

7.  p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction.

Authors:  Marc Brackertz; Zihua Gong; Jörg Leers; Rainer Renkawitz
Journal:  Nucleic Acids Res       Date:  2006-01-13       Impact factor: 16.971

8.  The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.

Authors:  Won-Il Choi; Bu-Nam Jeon; Jae-Hyeon Yoon; Dong-In Koh; Myung-Hwa Kim; Mi-Young Yu; Kyung-Mi Lee; Youngsoo Kim; Kyunggon Kim; Sujin Susanne Hur; Choong-Eun Lee; Kyung-Sup Kim; Man-Wook Hur
Journal:  Nucleic Acids Res       Date:  2013-05-08       Impact factor: 16.971

9.  JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.

Authors:  Anna L Godfrey; Edwin Chen; Francesca Pagano; Christina A Ortmann; Yvonne Silber; Beatriz Bellosillo; Paola Guglielmelli; Claire N Harrison; John T Reilly; Frank Stegelmann; Fontanet Bijou; Eric Lippert; Mary F McMullin; Jean-Michel Boiron; Konstanze Döhner; Alessandro M Vannucchi; Carlos Besses; Peter J Campbell; Anthony R Green
Journal:  Blood       Date:  2012-08-16       Impact factor: 22.113

10.  JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease.

Authors:  Juan Li; David G Kent; Anna L Godfrey; Harriet Manning; Jyoti Nangalia; Athar Aziz; Edwin Chen; Kourosh Saeb-Parsy; Juergen Fink; Rachel Sneade; Tina L Hamilton; Dean C Pask; Yvonne Silber; Xiaodong Zhao; Cedric Ghevaert; Pentao Liu; Anthony R Green
Journal:  Blood       Date:  2014-04-01       Impact factor: 22.113
  10 in total
  1 in total

1.  A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm.

Authors:  D A Casolari; T Nguyen; C M Butcher; D G Iarossi; C N Hahn; S C Bray; P Neufing; W T Parker; J Feng; K Z Y Maung; A Wee; L Vidovic; C H Kok; P G Bardy; S Branford; I D Lewis; S W Lane; H S Scott; D M Ross; R J D'Andrea
Journal:  Sci Rep       Date:  2017-05-26       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.